<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To correlate cyclooxygenase-2 (COX-2) expression profile with clinical and pathological variables to assess their prognostic/predictive value in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Archival <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples were analyzed using immunohistochemistry for COX-2 expression in 94 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were diagnosed and treated at the Departments of Surgery and <z:hpo ids='HP_0002664'>Oncology</z:hpo>, King Abdulaziz University Hospital, Saudi Arabia </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Fifty-six percent of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> showed positive cytoplasmic COX-2 expression, whereas 44% of cases were completely COX-2-negative </plain></SENT>
<SENT sid="4" pm="."><plain>There were no significant correlations between COX-2 expression and sex, age, grade or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> location </plain></SENT>
<SENT sid="5" pm="."><plain>However, COX-2 expression revealed a significant correlation with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage (P = 0.01) and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P = 0.02), and a borderline association with lymph node involvement (P = 0.07) </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> with high COX-2 expression showed a higher recurrence rate than <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with no expression (P &lt; 0.009) </plain></SENT>
<SENT sid="7" pm="."><plain>In univariate Kaplan-Meier survival analysis, there was a significant (P = 0.026) difference in disease-free survival between COX-2-positive and negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in favor of the latter </plain></SENT>
<SENT sid="8" pm="."><plain>COX-2 expression did not significantly predict disease-specific survival, which was much shorter for COX-2-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>In multivariate (COX) models, COX-2 did not appear among the independent predictors of disease-free survival or disease-specific survival </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: COX-2 expression seems to provide useful prognostic information in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, while predicting the patients at high risk for <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> </plain></SENT>
</text></document>